LAIV


Also found in: Dictionary, Thesaurus, Acronyms, Encyclopedia.
Related to LAIV: live

LAIV

live attenuated influenza vaccine.
See: vaccine
References in periodicals archive ?
Persons who wish to be vaccinated but do not have an indication can receive TIV or, if healthy and in the proper age group, can receive LAIV.
A randomized, double-blind, placebo-controlled trial among 1,602 healthy children aged 15-71 months assessed the efficacy of LAIV against culture-confirmed influenza during two seasons (233,234).
ACIP realizes that due to programmatic constraints it would be difficult to vaccinate all children with LAIV this year and is emphasizing that it should be implemented when feasible this year but no later than the 2015 to 2016 influenza season.
Based on review of the efficacy data, LAIV was associated with a decreased risk of lab-confirmed influenza among 2- to 8-year-olds based on high-quality randomized evidence, but it showed no difference over IIV among 9- to 18-year-olds based on very-low-quality observational data, Dr.
In June, the Advisory Committee on Immunization Practices (ACIP) proposed new recommendations regarding the use of LAIV and IIV for young healthy children.
** LAIV should not be administered to family members or close contacts of those who are immunosuppressed and require a protective environment, while TIV can be used in this situation
Both LAIV and TIV contain strains of influenza viruses that are antigenically equivalent to the annually recommended strains: one influenza A (H3N2) virus, one influenza A (H1N1) virus, and one influenza B virus.
Investigators detected influenza shedding in 31 of 115 LAIV recipients (27%) 3 days after they received the vaccine.
If the LAIV is not immediately available, IIV [inactivated influenza vaccine] should be used, according to the recommendation.
(1-2) There are 2 types of vaccines available; trivalent inactivated influenza vaccine (TIA) and live attenuated influenza vaccine (LAIV).
Live attenuated influenza vaccine (LAIV) is likely to be an option for all individuals with egg allergies, regardless of allergy severity, because the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices voted to approve proposed amendments to the existing recommendations regarding administration of LAIV in individuals with egg allergies.